145 related articles for article (PubMed ID: 31544717)
1. From Receptor Selectivity to Functional Selectivity: The Rise of Biased Agonism in 5-HT1A Receptor Drug Discovery.
Sniecikowska J; Newman-Tancredi A; Kolaczkowski M
Curr Top Med Chem; 2019; 19(26):2393-2420. PubMed ID: 31544717
[TBL] [Abstract][Full Text] [Related]
2. Novel Aryloxyethyl Derivatives of 1-(1-Benzoylpiperidin-4-yl)methanamine as the Extracellular Regulated Kinases 1/2 (ERK1/2) Phosphorylation-Preferring Serotonin 5-HT
Sniecikowska J; Gluch-Lutwin M; Bucki A; Więckowska A; Siwek A; Jastrzebska-Wiesek M; Partyka A; Wilczyńska D; Pytka K; Pociecha K; Cios A; Wyska E; Wesołowska A; Pawłowski M; Varney MA; Newman-Tancredi A; Kolaczkowski M
J Med Chem; 2019 Mar; 62(5):2750-2771. PubMed ID: 30721053
[TBL] [Abstract][Full Text] [Related]
3. Translating biased agonists from molecules to medications: Serotonin 5-HT
Newman-Tancredi A; Depoortère RY; Kleven MS; Kołaczkowski M; Zimmer L
Pharmacol Ther; 2022 Jan; 229():107937. PubMed ID: 34174274
[TBL] [Abstract][Full Text] [Related]
4. Activity of Serotonin 5-HT
Jastrzębska-Więsek M; Partyka A; Rychtyk J; Śniecikowska J; Kołaczkowski M; Wesołowska A; Varney MA; Newman-Tancredi A
ACS Chem Neurosci; 2018 May; 9(5):1040-1050. PubMed ID: 29266914
[TBL] [Abstract][Full Text] [Related]
5. [18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging.
Lemoine L; Verdurand M; Vacher B; Blanc E; Le Bars D; Newman-Tancredi A; Zimmer L
Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):594-605. PubMed ID: 19789870
[TBL] [Abstract][Full Text] [Related]
6. Serotonin 5-HT
Levigoureux E; Vidal B; Fieux S; Bouillot C; Emery S; Newman-Tancredi A; Zimmer L
ACS Chem Neurosci; 2019 Jul; 10(7):3108-3119. PubMed ID: 30576601
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Novel pERK1/2- or β-Arrestin-Preferring 5-HT
Sniecikowska J; Gluch-Lutwin M; Bucki A; Więckowska A; Siwek A; Jastrzebska-Wiesek M; Partyka A; Wilczyńska D; Pytka K; Latacz G; Przejczowska-Pomierny K; Wyska E; Wesołowska A; Pawłowski M; Newman-Tancredi A; Kolaczkowski M
J Med Chem; 2020 Oct; 63(19):10946-10971. PubMed ID: 32883072
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological MRI to investigate the functional selectivity of 5-HT
Vidal B; Bolbos R; Redouté J; Langlois JB; Costes N; Newman-Tancredi A; Zimmer L
Neuropharmacology; 2020 Aug; 172():107867. PubMed ID: 31783063
[TBL] [Abstract][Full Text] [Related]
9. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C; Kleven M
J Med Chem; 1999 May; 42(9):1648-60. PubMed ID: 10229633
[TBL] [Abstract][Full Text] [Related]
10. NLX-101, a highly selective 5-HT
Depoortère R; Auclair AL; Newman-Tancredi A
Behav Brain Res; 2021 Mar; 401():113082. PubMed ID: 33358917
[TBL] [Abstract][Full Text] [Related]
11. 5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential.
Koek W; Vacher B; Cosi C; Assié MB; Patoiseau JF; Pauwels PJ; Colpaert FC
Eur J Pharmacol; 2001 May; 420(2-3):103-12. PubMed ID: 11408031
[TBL] [Abstract][Full Text] [Related]
12. Effects of the Serotonin 5-HT
Newman-Tancredi A; Varney MA; McCreary AC
Neurochem Res; 2018 May; 43(5):1035-1046. PubMed ID: 29572645
[TBL] [Abstract][Full Text] [Related]
13. The selective 5-HT
Głuch-Lutwin M; Sałaciak K; Gawalska A; Jamrozik M; Sniecikowska J; Newman-Tancredi A; Kołaczkowski M; Pytka K
Psychopharmacology (Berl); 2021 Aug; 238(8):2249-2260. PubMed ID: 33973045
[TBL] [Abstract][Full Text] [Related]
14. In vivo biased agonism at 5-HT
Vidal B; Fieux S; Redouté J; Villien M; Bonnefoi F; Le Bars D; Newman-Tancredi A; Costes N; Zimmer L
Neuropsychopharmacology; 2018 Oct; 43(11):2310-2319. PubMed ID: 30030540
[TBL] [Abstract][Full Text] [Related]
15. The 5-HT
Papp M; Gruca P; Lason M; Litwa E; Newman-Tancredi A; Depoortère R
Psychopharmacology (Berl); 2023 Nov; 240(11):2419-2433. PubMed ID: 37310446
[TBL] [Abstract][Full Text] [Related]
16. Acute and Repeated Administration of NLX-101, a Selective Serotonin-1A Receptor Biased Agonist, Reduces Audiogenic Seizures in Developing Fmr1 Knockout Mice.
Tao X; Newman-Tancredi A; Varney MA; Razak KA
Neuroscience; 2023 Jan; 509():113-124. PubMed ID: 36410632
[TBL] [Abstract][Full Text] [Related]
17. Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.
Iderberg H; McCreary AC; Varney MA; Cenci MA; Newman-Tancredi A
Neuropharmacology; 2015 Jun; 93():52-67. PubMed ID: 25645393
[TBL] [Abstract][Full Text] [Related]
18. The Serotonin 1A (5-HT
Smith ALW; Harmer CJ; Cowen PJ; Murphy SE
CNS Drugs; 2023 Jul; 37(7):571-585. PubMed ID: 37386328
[TBL] [Abstract][Full Text] [Related]
19. The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, like ketamine, elicit rapid-acting antidepressant activity in the rat chronic mild stress model via cortical mechanisms.
Papp M; Gruca P; Litwa E; Lason M; Newman-Tancredi A; Depoortère R
J Psychopharmacol; 2024 Jun; ():2698811241254832. PubMed ID: 38825869
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
